Skip to content

Clinical trials

Phase 3 Parkinson Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 3 Clear all

236 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20026
20038
200415
200510
200613
200721
20086
200919
201015
201110
20127
20138
201410
201510
20165
20175
20188
201910
20209
20215
20223
20231
20243
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed180
Terminated26
Recruiting10
Unknown status9
Active, not recruiting4
Not yet recruiting4
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB Pharma15
AbbVie10
Boehringer Ingelheim10
GlaxoSmithKline9
Kyowa Kirin Co., Ltd.8
Newron Pharmaceuticals SPA8
Impax Laboratories, LLC7
Solvay Pharmaceuticals7
Teva Branded Pharmaceutical Products R&D, Inc.6
Adamas Pharmaceuticals, Inc.5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease236
Dyskinesias21
Parkinsonian Disorders15
Movement Disorders6
Brain Diseases5
Central Nervous System Diseases5
Nervous System Diseases5
Neurodegenerative Diseases5
Dizziness4
Essential Tremor4

Trials

Showing 1 to 25 of 236. Each trial links to its page on Pharma Observatory.

136 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.